TABLE 2.
|
Paclitaxel in the Presence of
|
||||
---|---|---|---|---|---|
0 μM Q2 | 1 μM Q2 | 2 μM Q2 | 4 μM Q2 | 6 μM Q2 | |
MCF-7 | 3.1 ± 1.0 nM | N.A. | N.A. | N.A. | N.A. |
MCF-7/DX1 | 9.03 ± 0.03 μM | 6.3 ± 0.2 μM | 2.0 ± 0.3 μM | 3.0 ± 1.1 nM | 4.0 ± 1.0 nM |
N.A., not available.
|
Paclitaxel in the Presence of
|
||||
---|---|---|---|---|---|
0 μM Q2 | 1 μM Q2 | 2 μM Q2 | 4 μM Q2 | 6 μM Q2 | |
MCF-7 | 3.1 ± 1.0 nM | N.A. | N.A. | N.A. | N.A. |
MCF-7/DX1 | 9.03 ± 0.03 μM | 6.3 ± 0.2 μM | 2.0 ± 0.3 μM | 3.0 ± 1.1 nM | 4.0 ± 1.0 nM |
N.A., not available.